Chemours Co (CC)
Pretax margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | -319,000 | 741,000 | 676,000 | 179,000 | -124,000 |
| Revenue | US$ in thousands | 5,818,000 | 6,638,000 | 6,139,000 | 4,737,000 | 5,318,000 |
| Pretax margin | -5.48% | 11.16% | 11.01% | 3.78% | -2.33% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $-319,000K ÷ $5,818,000K
= -5.48%
The pretax margin of Chemours Co has shown fluctuating trends over the past five years. In 2023, the company reported a negative pretax margin of -5.48%, reflecting a decline in profitability compared to the previous year. This decrease contrasts with the positive trend observed from 2020 to 2022, where pretax margins ranged from 3.78% to 11.16%. The significant improvement in profitability between 2020 and 2022 indicates the company's ability to generate higher earnings before taxes relative to its revenue. However, the negative pretax margin in 2019 (-2.33%) suggests a period of lower profitability. Overall, analyzing Chemours Co's pretax margin reveals fluctuations in performance, emphasizing the importance of closely monitoring the company's profitability metrics.
Peer comparison
Dec 31, 2023